In SOUTH SAN FRANCISCO, Calif., Circle Pharma, Inc., a clinical-stage biopharmaceutical company focusing on innovative targeted macrocycle therapeutics for challenging cancers, has revealed a partnership with Eli Lilly and Company. This agreement allows Circle Pharma to utilize Lilly TuneLab, an advanced artificial intelligence and machine learning platform intended to speed up the creation of new medications. This collaboration is anticipated to aid biotech companies in accessing potent drug development tools.